Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 432Bone health and osteoporosis researchVitamin D Research StudiesMenopause: Health Impacts and Treatments

The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.

Effect of Estrogen on Calcium Absorption and Serum Vitamin D Metabolites in Postmenopausal Osteoporosis*

GALLAGHER, J. C., RIGGS, B. LAWRENCE, DELUCA, HECTOR F.·1980·The Journal of Clinical Endocrinology & Metabolism

Abstract

Osteoporotic women have decreased calcium absorption and decreased serum 1,25-dihydroxyvitamin D [1,25-(OH)2D] and are usually in negative calcium balance. Estrogen therapy improves calcium balance in patients with postmenopausal osteoporosis. In birds, estrogen administration increases the conversion of 25-hydroxyvitamin D (25OHD) to 1,25-(OH)2D. To determine if estrogen therapy affects vitamin D metabolism in human subjects, we studied 21 osteoporotic women before and after 6 months of treatment. We compared groups treated with either placebo (9 patients) or conjugated equine estrogen (1.2-2.5 mg/day; 12 patients). Fractional calcium absorption (mean +/- SE) was unchanged after treatment with placebo (0.51 +/- 0.03 to 0.52 +/- 0.01) but increased after treatment with estrogen (0.53 +/- 0.02 to 0.65 +/- 0.04; P < 0.005). The increase after estrogen was similar to the increase observed in 10 additional osteoporotic women treated for 6 months with a small dose of 0.5 microgram/day 1,25-(OH)2D (0.54 +/- 0.03 to 0.68 +/- 0.04; P < 0.005). Serum 1,25-(OH)2D was unchanged after treatment with placebo (27.5 +/- 1.3 to 27.6 +/- 1.7 pg/ml) but increased after treatment with estrogen (23.6 +/- 2.7 to 33.2 +/- 3.7 pg/ml; P < 0.005). Serum immunoreactive parathyroid hormone (PTH) increased (23.0 +/- 4.2 to 32.7 +/- 4.6 microliter eq/ml; P < 0.05) after estrogen but not after placebo treatment. After treatment with estrogen, the increases in serum immunoreactive PTH and serum 1,25-(OH)2D were correlated (r = 0.68; P < 0.05), and the increases in serum 1,25-(OH)2D and calcium absorption were highly correlated (r = 0.89; P < 0.001). We conclude that estrogen treatment increases calcium absorption in postmenopausal osteoporosis by increasing serum 1,25(OH)2D. This effect appears to be mediated indirectly through stimulation of renal 1 alpha-hydroxylase by increased serum PTH.

Overview

Integrity signals

Registry

Crossref · 10.1210/jcem-51-6-1359

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 41 references

Cited by

See all 432

Metadata

Authors
GALLAGHER, J. C., RIGGS, B. L., & DELUCA, H. F.
Affiliations
Mayo Clinic (US)
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
1980-12
Volume
51
Issue
6
Pages
1359-1364
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2115932658
Cited by
428
References
41
Citations by year
2026: 2 · 2025: 2 · 2024: 9 · 2023: 4 · 2022: 7 · 2021: 7 · 2020: 12 · 2019: 9 · 2018: 9 · 2017: 7 · 2016: 6 · 2015: 5 · 2014: 8 · 2013: 8 · 2012: 7
FWCI
37.76
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
Keywords
estrogen therapy, postmenopausal osteoporosis, calcium absorption, vitamin D metabolism, 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D, parathyroid hormone, conjugated equine estrogens, calcium balance, bone loss, women's health
MeSH terms
Aged, Calcitriol, Calcium, Clinical Trials as Topic, Dihydroxycholecalciferols, Estrogens, Conjugated (USP), Female, Humans, Hydroxycholecalciferols, Hydroxyproline, Menopause, Middle Aged, Osteoporosis, Parathyroid Hormone, Phosphates, Placebos

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of Estrogen on Calcium Absorption and Serum Vitamin D Metabolites in Postmenopausal Osteoporosis*. https://app.cochat.ai/papers/10.1210/jcem-51-6-1359
The paper
GALLAGHER, J. C., RIGGS, B. L., & DELUCA, H. F. (1980). Effect of Estrogen on Calcium Absorption and Serum Vitamin D Metabolites in Postmenopausal Osteoporosis*. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jcem-51-6-1359

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.